Proliferating cell nuclear antigen (PCNA) IVD, antibody

This category covers antibodies designed to detect proliferating cell nuclear antigen (PCNA) protein in clinical specimens. These reagents bind specifically to PCNA, a marker associated with cell proliferation, and are used in diagnostic workflows to assess tissue samples. They support qualitative or quantitative analysis in laboratory settings, aiding in the evaluation of cellular activity and growth patterns.

These devices are in vitro diagnostic (IVD) antibodies, meaning they are intended for use outside the body on collected samples. They are supplied as immunoglobulins formulated for laboratory use and typically require validation within a specific testing platform. Regulatory oversight follows standard IVD pathways, with classification and requirements varying by jurisdiction and intended use.